Facet browsing currently unavailable
Page 1 of 1 results
Sort by: relevance publication year
Showing DOI matching
10.1158/1078-0432.CCR-20-4726
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study JOURNAL ARTICLE published 1 June 2021 in Clinical Cancer Research |